Home › Funds › Nuveen, LLC › REGN

Nuveen, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Nuveen, LLC reported holding 1,955,949 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$1.48B, representing 0.36% of its reported portfolio and ranking #49 among its reported holdings. Nuveen, LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)1.96M sh
Reported value held$1.48B
Portfolio Weight0.36%
First reportedQ1 2025
Last changeReduce
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Nuveen, LLC's REGN position evolved

Nuveen, LLC first disclosed a stake in REGN in Q1 2025 at 542,018 shares (US$343.8M). The position peaked in Q1 2026 at 2,065,064 shares, worth US$1.60B. Across 7 filings, Nuveen, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,955,949 shares valued at US$1.48B — a reduction of -64,025 shares quarter over quarter.. Notable position changes include a 55% increase in Q2 2025 (shares rose 8% over the following quarter), a 40% increase in Q3 2025 (shares rose 36% over the following quarter), a 71% increase in Q4 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 542.02K $343.76M New
Q2 2025 841.55K $441.81M Add
Q3 2025 1.18M $660.82M Add
Q4 2025 2.01M $1.55B Add
Q1 2026 2.07M $1.60B Add
Q2 2026 2.02M $1.26B Reduce
Q3 2026 1.96M $1.48B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 30 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Nuveen, LLC held REGN?

Nuveen, LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Nuveen, LLC's current position in REGN?

As of Q3 2026, Nuveen, LLC holds 1.96M shares of REGN (REGENERON PHARMACEUTICALS), valued at $1.48B, representing 0.36% of its reported portfolio and ranking #49.

Has Nuveen, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Nuveen, LLC reduced its position in REGN. The position peaked in Q1 2026 at 2.07M shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.